Advertisement

Reactions Weekly

, Volume 1633, Issue 1, pp 33–33 | Cite as

Alemtuzumab/warfarin

Various toxicities: 5 case reports
Case report
  • 16 Downloads

Reference

  1. Fox EJ, et al. A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis. European Journal of Neurology 19: 307-311, No. 2, Feb 2012. Available from: URL: http://doi.org/10.1111/j.1468-1331.2011.03507.x - USA

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations